Russell Investments Group Ltd. boosted its position in PACS Group, Inc. (NYSE:PACS - Free Report) by 26.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 311,871 shares of the company's stock after purchasing an additional 64,734 shares during the period. Russell Investments Group Ltd. owned about 0.20% of PACS Group worth $4,089,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors also recently added to or reduced their stakes in the business. JPMorgan Chase & Co. boosted its holdings in PACS Group by 6.1% during the fourth quarter. JPMorgan Chase & Co. now owns 1,350,842 shares of the company's stock worth $17,710,000 after buying an additional 78,122 shares in the last quarter. Barclays PLC grew its holdings in shares of PACS Group by 651.3% in the 3rd quarter. Barclays PLC now owns 63,366 shares of the company's stock worth $2,532,000 after acquiring an additional 54,932 shares during the period. Teacher Retirement System of Texas increased its stake in PACS Group by 526.1% in the 4th quarter. Teacher Retirement System of Texas now owns 56,210 shares of the company's stock valued at $737,000 after purchasing an additional 47,232 shares in the last quarter. Assenagon Asset Management S.A. acquired a new position in PACS Group during the fourth quarter worth $772,000. Finally, State Street Corp boosted its position in PACS Group by 119.5% during the third quarter. State Street Corp now owns 754,221 shares of the company's stock worth $30,146,000 after purchasing an additional 410,606 shares in the last quarter.
Wall Street Analyst Weigh In
A number of equities research analysts have commented on the company. Truist Financial lowered their target price on PACS Group from $46.00 to $32.00 and set a "buy" rating on the stock in a report on Monday, January 6th. Macquarie cut their price objective on shares of PACS Group from $42.00 to $24.00 and set an "outperform" rating for the company in a research report on Monday, January 6th. One research analyst has rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat.com, PACS Group currently has a consensus rating of "Moderate Buy" and a consensus price target of $34.00.
Get Our Latest Report on PACS
PACS Group Trading Down 7.3 %
Shares of NYSE PACS traded down $0.68 on Monday, reaching $8.58. 809,292 shares of the company traded hands, compared to its average volume of 784,783. The company has a 50 day moving average of $11.48 and a 200 day moving average of $17.62. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 0.82. PACS Group, Inc. has a fifty-two week low of $8.28 and a fifty-two week high of $43.92.
PACS Group Profile
(
Free Report)
PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.
See Also

Before you consider PACS Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PACS Group wasn't on the list.
While PACS Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.